Early experience with Tigertriever for stroke clot removal
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at the early experience using the Tigertriever device to remove blood clots from large arteries in the brain. It may help researchers understand how well the device works in real-life practice for people having a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You had a large vessel occlusion (a blockage in a major brain artery) and were treated with the Tigertriever device as the first treatment option.
- You must sign a consent form to participate.
- You have not had a brain bleed, stroke, clot-busting medicine, or another clot-removal procedure in the last 3 months.
- You had no major disability before this stroke (you could care for yourself without help).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the blood clots removed from the brain during a procedure called thrombectomy. By studying them, researchers hope to learn more about how to treat strokes and what causes them, which could help improve care.
This study records outcomes for people having an acute ischemic stroke treated with an endovascular (catheter-based) procedure. It may help doctors understand how clot-removal treatment works in different patients and hospitals.
This trial tests a new approach to see if removing clots from medium-sized brain blood vessels can help more patients recover from stroke. It aims to expand the use of a standard clot-removal procedure to people with less severe symptoms or blockages in smaller vessels.
This trial tests if removing clots from smaller arteries in the brain (not the main ones) helps people who had a stroke and can't get standard clot-busting medicine. It compares clot removal to usual care for strokes caused by these medium-sized vessel blockages.
This trial tests whether giving a clot-busting drug (alteplase) directly into the brain artery after a successful clot removal improves recovery in people with severe stroke. It is for patients who have had a thrombectomy and still have a large blocked artery in the front of the brain.
This trial compares a procedure to remove a blood clot from a brain artery (endovascular therapy) with standard medicines alone, for people who had a large-vessel stroke more than 24 hours ago (up to 30 days). It aims to see if the procedure can still help improve recovery even after this longer time window, especially if symptoms are fluctuating or worsening.
Hear when a new Blood Clot trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.